Stefan Oschmann

Stefan Oschmann started his career in pharma occupying diverse managing positions at MSD. He then worked at Merck, starting by leading the Healthcare department and developing the global strategy to become CEO of Merck in 2016. With his award-winning leadership skills he served Merck until 2021. Currently, Stefan works as chairman at both UCB and AiCuris Anti-infective Cures.